AstraZeneca Newark Transformation Image
Newark, Delaware, United States

AstraZeneca Newark Transformation

Lendlease managed AstraZeneca's (AZ) multi-phased Newark Facility Transformation (NFT) project in Newark, Delaware consisting of the construction of a new oral solid dosage (OSD) formulation suite, and renovations and upgrades to the facility's packaging lines, warehouse and support areas.

AstraZeneca Newark Transformation

Client
AstraZeneca Pharmaceuticals LP

Location
Newark, Delaware, United States

Completion
2017

Area
120,000 square feet

Assignments
Construction Management, Cost Plus

Architect
CRB

Project outcome

All work was performed while the facility remains fully operational. In March 2016, the Lendlease NFT project team, was awarded a 'Gold Star Safety' at AstraZeneca's Global Engineering's North America Safety awards ceremony.